The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies

Journal of Virology

Volumn 70, Issue 4, 1996, Pages 2562-2568

  Szekely, Laszlo ^a   Pokrovskaja, Katja ^a   Jiang, Wei Qin ^b   De The, Hugues ^c,d   Ringertz, Nils ^b   Klein, George ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SAINT LOUIS HOSPITAL   (France)

^d AP HP   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; TUMOR PROTEIN; VIRUS ANTIGEN;

ARTICLE; B LYMPHOCYTE; CELL NUCLEUS INCLUSION BODY; CELLULAR DISTRIBUTION; CHROMATIN; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HEAT SHOCK; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MITOSIS; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN LOCALIZATION; STRESS; SURFACE TENSION; VIRUS CELL TRANSFORMATION; VIRUS INFECTION;

ANTIGENS, VIRAL; B-LYMPHOCYTES; CELL LINE; CHROMATIN; DNA-BINDING PROTEINS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HEAT; HERPESVIRUS 4, HUMAN; HUMANS; MITOSIS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0029912985     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.4.2562-2568.1996     Document Type: Article

References (33)

1. Alfieri, C., M. Birkenbach, and E. Kieff. 1991. Early events in Epstein-Barr virus infection of human B lymphocytes Virology 181:595-608. (Erratum, 185:946.)
2. Allday, M. J., D. H. Crawford, and B. E. Griffin. 1989 Epstein-Barr virus latent gene expression during the initiation of B cell immortalization. J. Gen. Virol. 70:1755-1764.
3. Brasch, K., and R. L. Ochs. 1992. Nuclear bodies (NBs). a newly "rediscovered" organelle. Exp. Cell Res. 202:211-223
4. Carvalho, T., J. S. Seeler, K. Ohman, P. Jordan, U. Pettersson, G. Akusjarvi, M. Carmofonseca, and A. Dejean. 1995 Targeting of adenovirus E1a and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J. Cell Biol. 131:45-56
5. Cohen, J. I., F. Wang, J. Mannick, and E. Kieff. 1989. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc. Natl Acad. Sci. USA 86:9558-9562.
6. Daniel, M. T., M. Koken, O. Romagne, S. Barbey, A. Bazarbachi, M. Stadler, M. C. Guillemin, L. Degos, C. Chomienne, and H. de The. 1993. PML protein expression in hematopoietic and acute promyelocytic leukemia cells Blood 82:1858-1867.
7. de The, H., C. Lavau, A. Marchio, C. Chomienne, L. Degos, and A. Dejean. 1991. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675-684.
8. de The, H., M. Riviere, and W. Bernhard. 1960. Bull Cancer 47:570-584.
9. Dyck, J. A., G. G. Maul, W. H. Miller, Jr., J. D. Chen, A. Kakizuka, and R. M. Evans. 1994. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76:333-343.
10. Everett, R. D., and G. G. Maul. 1994. HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J. 13:5062-5069.
11. Finke, J., M. Rowe, B. Kallin, I. Ernberg, A. Rosen, J. Dillner, and G. Klein. 1987. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines. J. Virol. 61:3870-3878.
12. Guldner, H., C. Szostecki, T. Grotzinger, and H. Will. 1992. IFN enhances expression of Sp100. an autoantigen in primary biliary cirrhosis. J. Immunol. 149:4067-4073.
13. Harlow, E., and D. Lane. (ed.). 1988. Antibodies: a laboratory manual Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
14. Jiang, W. Q., L. Szekely, V. Wendel-Hansen, N. Ringertz, G. Klein, and A. Rosén. 1991 Co-localization of the retinoblastoma protein and the Epstein-Barr virus-encoded nuclear antigen EBNA-5. Exp. Cell Res. 197:314-318.
15. Jiang, W. Q., V. Wendel-Hansen, A. Lundkvist, N. Ringertz, G. Klein, and A. Rosén. 1991 Intranuclear distribution of Epstein-Barr virus-encoded nuclear antigens EBNA-1, -2, -3, and -5. J. Cell Sci. 99:497-502.
16. Kakizuka, A., W. H. Miller, Jr., K. Umesono, R. P. Warrell, Jr., S. R. Frankel, V. V. Murty, E. Dmitrovsky, and R. M. Evans. 1991. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66:663-674.
17. Koken, M. H., F. Puvion-Dutilleul, M. C. Guillemin, A. Viron, G. Linares-Cruz, N. Stuurman, L. de Jong, C. Szostecki, F. Calvo, C. Chomienne, et al. 1994. The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J. 13:1073-1083.
18. Koken, M. H. M., G. Linares-Cruz, F. Quignon, A. Viron, M. K. Chelbi-Alix, J. Sobczak-Thepot, L. Juhlin, L. Degos, F. Calvo, and H. de The. 1995. The PML growth-suppressor has altered expression in human oncogenesis. Oncogene 10:1315-1324.
19. Korioth, F., C. Gieffers, G. G. Maul, and J. Frev. 1995. Molecular characterization of NDP52, a novel protein of the nuclear domain 10, which is redistributed upon virus infection and interferon treatment. J. Cell Biol. 130:1-13.
20. Mannick, J. B., J. I. Cohen, M. Birkenbach, A. Marchini, and E. Kieff. 1991. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J. Virol. 65:6826-6837.
21. Maul, G. G., and R. D. Everett. 1994. The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0. J. Gen Virol. 75:1223-1233.
22. Mu, Z. M., K. V. Chin, J. H. Liu, G. Lozano, and K. S. Chang. 1994. PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol. Cell. Biol. 14:6858-6867.
23. Mullen, M. A., S. Gerstberger, D. M. Ciufo, J. D. Mosca, and G. S. Hayward. 1995 Evaluation of colocalization interactions between the IE110, IE175, and IE63 transactivator proteins of herpes simplex virus within subcellular punctate structures. J. Virol. 69:476-491.
24. Petti, L., C. Sample, and E. Kieff. 1990. Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear proteins Virology 176:563-574.
25. Schlammadinger, J. 1990. Immunofluorescence detection of nuclear antigens in supramolecular chromatin spreads. Methods Mol. Cell. Biol. 1:235-241.
26. Sinclair, A. J., I. Palmero, G. Peters, and P. J. Farrell. 1994. EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J. 13:3321-3328.
27. Stadler, M., M. K. Chelbi-Alix, M. H. M. Koken, L. Venturini C. Lee, A. Saib, F. Quignon, L. Pelicano, M.-C. Guillemin, C. Schindler, and H. de The. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and GAS element. Oneogene, in press
28. Szekely, L., W.-Q. Jiang, K. Pokrovskaja, K. G. Wiman, G. Klein, and N. Ringertz. 1995. Reversible nucleolar translocation of EBV encoded EBNA-5 and Hsp70 proteins after exposure to heat shock or cell density congestion J. Gen. Virol. 76:2423-2432.
29. Szekely, L., K. Pokrovskaja, W.-Q. Jiang, G. Selivanova, M. Lowbeer, N. Ringertz, K. G. Wiman, and G. Klein. 1995. Resting B-cells, EBV infected B-blasts and established lymphoblastoid cell lines differ in their Rb, p53 and EBNA-5 expression patterns. Oneogene 10:1869-1874.
30. Szekely, L., G. Selivanova, K. P. Magnusson, G. Klein, and K. G. Wiman. 1993. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc. Natl. Acad. Sci. USA 90:5455-5459.
31. Thiry, M. 1995. Nucleic acid compartmentalization within the cell nucleus by in situ transferase-immunogold techniques. Microscopy Res. Tech 31:4-21.
32. Tomkinson, B., E. Robertson, and E. Kieff. 1993. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J. Virol. 67:2014-2025.
33. Weis, K., S. Rambaud, C. Lavau, J. Jansen, T. Carvalho, M. Carmo-Fonseca, A. Lamond, and A. Dejean. 1994. Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell 76:345-356.